Search Articles

View query in Help articles search

Search Results (1 to 10 of 11 Results)

Download search results: CSV END BibTex RIS


Predicting Pain in People With Sickle Cell Disease in the Day Hospital Using the Commercial Wearable Apple Watch: Feasibility Study

Predicting Pain in People With Sickle Cell Disease in the Day Hospital Using the Commercial Wearable Apple Watch: Feasibility Study

Shah et al looked at over 8000 individuals with sickle cell disease over a 3-year period and reported that each patient averaged 3.3 VOCs per year [6]. VOCs are associated with a decreased health-related quality of life and are a significant morbidity for individuals with sickle cell disease; it is the most common cause of hospitalization in SCD [5,7]. The treatment for VOCs is currently limited to analgesics such as opioids, which are given in proportion to the reported level of pain [8].

Rebecca Sofia Stojancic, Arvind Subramaniam, Caroline Vuong, Kumar Utkarsh, Nuran Golbasi, Olivia Fernandez, Nirmish Shah

JMIR Form Res 2023;7:e45355